Amy Lee

Amy Lee is an accomplished professional in the field of pharmacology and therapeutics, currently serving as the Director of In Vivo Pharmacology at AbCellera since January 2022. Prior experience includes roles at Genevant Sciences as a Consultant and a significant tenure at Arbutus Biopharma Corporation, where positions ranged from Senior Director in In Vivo Pharmacology to roles leading the development and clinical trial applications for various hepatitis therapeutics. Notable achievements encompass the FDA Emergency Use Authorization for TKM-Ebola and the development of lipid nanoparticle systems for siRNA delivery. Amy Lee’s academic background includes a Master’s and Bachelor’s degree in Microbiology and Immunology from The University of British Columbia.